Nirsevimab immunization effectively decreases the risk for RSV-related LRTI hospitalizations in an infant's first year.

A multicancer early detection blood test has a positive predictive value of 60.3% for patients without clinical suspicion of cancer.

Ceftazidime-avibactam therapy yields a high clinical response rate in patients with MDR Gram-negative pneumonia in routine practice.

A North Carolina company is recalling 167,639 pounds of raw goat, beef and pork that never went through required federal inspection.

Long-term fumarate therapy for multiple sclerosis, compared with anti-CD20 therapy, is linked to a reduced risk for infection.

The HPV-FASTER protocol offers an approach to assess health system capacity for delivering integrated HPV vaccination and cervical screening.

Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

The age-adjusted suicide rate increased from 2014 to 2017 and then did not change significantly from 2017 through 2024.

Data presented at USCHA 2026 demonstrate that culturally-responsive campaigns significantly improve HIV PrEP awareness.

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...